Goldman Sachs’s Quorum Health Corporation QHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-2,865,536
Closed -$1.29M 5667
2020
Q1
$1.29M Hold
2,865,536
﹤0.01% 3578
2019
Q4
$2.74M Sell
2,865,536
-3
-0% -$3 ﹤0.01% 3431
2019
Q3
$3.47M Sell
2,865,539
-1,620
-0.1% -$2.19K ﹤0.01% 3130
2019
Q2
$3.98M Sell
2,867,159
-135,506
-5% -$222K ﹤0.01% 3007
2019
Q1
$4.2M Buy
3,002,665
+107,312
+4% +$289K ﹤0.01% 3114
2018
Q4
$8.37M Sell
2,895,353
-23,788
-0.8% -$99.8K ﹤0.01% 2471
2018
Q3
$17.1M Buy
2,919,141
+416
+0% +$1.91K ﹤0.01% 2036
2018
Q2
$14.6M Buy
2,918,725
+289,816
+11% +$1.86M ﹤0.01% 2123
2018
Q1
$21.5M Buy
2,628,909
+3,179
+0.1% +$20.8K 0.01% 1806
2017
Q4
$16.4M Buy
2,625,730
+317,809
+14% +$1.6M ﹤0.01% 2089
2017
Q3
$12M Sell
2,307,921
-69,911
-3% -$284K ﹤0.01% 2423
2017
Q2
$9.87M Buy
2,377,832
+1,518,355
+177% +$6.23M ﹤0.01% 2516
2017
Q1
$4.68M Buy
859,477
+502,671
+141% +$4.09M ﹤0.01% 2987
2016
Q4
$2.59M Buy
356,806
+198,348
+125% +$1.19M ﹤0.01% 3607
2016
Q3
$993K Sell
158,458
-97,727
-38% -$801K ﹤0.01% 4405
2016
Q2
$2.74M Buy
+256,185
New +$2.99M ﹤0.01% 3347

Other funds holding QHC

Goldman Sachs's QHC Position: Q2 2020 in Review

Goldman Sachs sold out of Quorum Health Corporation (QHC) in Q2 2020, closing a stake of 2,865,536 shares — an estimated $1.29M sold.

Goldman Sachs first reported a position in QHC in Q2 2016 and held it in 16 quarters. The position peaked at $21.5M in Q1 2018. 9 funds tracked by Wall St. Rank hold QHC as of Q2 2020.

  • Goldman Sachs reported no remaining Quorum Health Corporation position as of Q2 2020 after selling out during the quarter.
  • Goldman Sachs sold 2,865,536 Quorum Health Corporation shares in Q2 2020, an estimated $1.29M.
  • Goldman Sachs first reported a position in Quorum Health Corporation in Q2 2016 and held it in 16 quarters.
  • Goldman Sachs's Quorum Health Corporation position peaked at $21.5M in Q1 2018.
  • 9 funds tracked by Wall St. Rank held Quorum Health Corporation as of Q2 2020.

Based on Goldman Sachs's 13F filing for Q2 2020, filed 12 Aug 2020.